NCT05720624View on ClinicalTrials.gov

Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 20, 2025

Primary Completion Date

October 20, 2025

Study Completion Date

October 20, 2025

Conditions
Malignant Central Nervous System Neoplasm
Interventions
DRUG

Anhydrous Enol-oxaloacetate

Given PO

OTHER

Best Practice

Receive standard of care therapy

PROCEDURE

Biospecimen Collection

Undergo collection of CSF and blood

PROCEDURE

Magnetic Resonance Spectroscopic Imaging

Undergo MRS imaging

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER